Parameters | Total | Postmenopausal | Premenopausal | P value |
---|---|---|---|---|
(n = 250) | (n = 107) | (n = 143) | ||
WHO | ||||
Central Obesity | 177(70.8%) | 94(87.9%) | 83(58.0%) | <0.0001 |
Raised Fasting Glucose | 39(15.6%) | 30(28.0%) | 9(6.3%) | <0.0001 |
Raised Triglyceride | 24(9.6%) | 15(14.0%) | 9(6.3%) | 0.0507 |
Raised Blood Pressure | 109(43.6%) | 64(59.8%) | 45(31.5%) | <0.0001 |
Reduced HDL-C | 47(18.8%) | 26(24.3%) | 21(14.7%) | 0.0710 |
NCEP ATP III | ||||
Abdominal Obesity | 160(64.0%) | 86(80.4%) | 74(51.7%) | <0.0001 |
Raised Fasting Glucose | 62(24.8%) | 39(36.5%) | 23(16.1%) | 0.0003 |
Raised Triglyceride | 24(9.6%) | 15(14.0%) | 9(6.3%) | 0.0507 |
Raised Blood Pressure | 160(64.0%) | 89(83.2%) | 71(49.7%) | <0.0001 |
Reduced HDL-C | 91(36.4%) | 45(42.1%) | 46(32.2%) | 0.1132 |
IDF | ||||
Abdominal Obesity | 215(86.0%) | 102(95.3%) | 113(79.0%) | 0.0002 |
Raised Fasting Glucose | 62(24.8%) | 39(36.5%) | 23(16.1%) | 0.0003 |
Raised Triglyceride | 24(9.6%) | 15(14.0%) | 9(6.3%) | 0.0507 |
Raised Blood Pressure | 160(64.0%) | 89(83.2%) | 71(49.7%) | <0.0001 |
Reduced HDL-C | 91(36.4%) | 45(42.1%) | 46(32.2%) | 0.1132 |
H_MS | ||||
Abdominal Obesity | 215(86.0%) | 102(95.3%) | 113(79.0%) | 0.0002 |
Raised Fasting Glucose | 62(24.8%) | 39(36.5%) | 23(16.1%) | 0.0003 |
Raised Triglyceride | 24(9.6%) | 15(14.0%) | 9(6.3%) | 0.0507 |
Raised Blood Pressure | 160(64.0%) | 89(83.2%) | 71(49.7%) | <0.0001 |
Reduced HDL-C | 91(36.4%) | 45(42.1%) | 46(32.2%) | 0.1132 |